| There’s nothing like a darkening economic climate
and rising competitive pressures to focus a business’
priorities, and few industries are being spared this
experience at the moment. Like their counterparts in
other commercial sectors, pharmaceutical organisations
are being forced to re-examine their core and non-core
activities in order to determine where new efficiencies
can be found, and to drive greater productivity and
competitive agility into their operations. This is leading
to a surge of interest in the outsourcing of non-core
activities, as pharma organisations attempt to sharpen
their practices and reduce time to market.
Fortunately, as these organisations are
discovering, there has been an increase
in the availability and scope of managed
services being offered by external
specialists, which now include partial
or complete outsourcing of regulatory
submission operations. |
